AutoICD API

D68.8

Billable

Other specified coagulation defects

Other specified coagulation defects

Status

Billable / Specific

Block

D65-D69

Parent Code

D68

ICD-11 Mapping

1 equivalent

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • COVID-19 associated coagulopathy

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

Excludes 2

Conditions not included here, but the patient may have both

Code Also

A second code may be required; sequencing depends on circumstances

  • , if applicable, associated condition
Related Codes(8)
D68.0

Von Willebrand disease

D68.1

Hereditary factor XI deficiency

BillableD68.2

Hereditary deficiency of other clotting factors

BillableD68.3

Hemorrhagic disorder due to circulating anticoagulants

D68.4

Acquired coagulation factor deficiency

BillableD68.5

Primary thrombophilia

D68.6

Other thrombophilia

D68.9

Coagulation defect, unspecified

Billable
ICD-11 Equivalents(1)

ICD-11 Equivalents

View full mapping

Corresponding ICD-11 codes from the WHO crosswalk mapping

3B4ZCoagulation defects, unspecifiedequivalentPrimary
Also Known As / Clinical Terms(200)

SNOMED CT

UMLS

Clinical Terms

  • COVID-19-Associated Coagulopathy
  • Acquired hypofibrinogenaemia
  • Hereditary combined coagulation factor deficiency
  • Hypofibrinogenaemia
  • Decreased fibrinolysis
  • Alpha-2-antiplasmin deficiency
  • FMFD syndrome, type I
  • Circulating anticoagulant disorder
  • Acquired inhibitor of coagulation
  • Anticoagulant excess without bleeding
  • Disorder of fibrinolysis
  • Blood coagulation disorder, categorized by value of screening test
  • Bleeding disorder due to deficiency of calcium and diacylglycerol-regulated guanine nucleotide exchange factor I
  • Factors II, VII, IX AND X deficiency
  • Thrombomodulin-related coagulopathy
  • Anti-factor II disorder
  • Afibrinogenemia
  • Bleeding disorder due to calcium and DAG-regulated guanine exchange factor-1 deficiency
  • Disorder involving the fibrinolytic system
  • Hereditary hypoplasminogenaemia
  • Combined coagulation factor deficiency
  • Familial multiple factor deficiency syndrome, type III
  • SARS-CoV-2-Associated Coagulopathy
  • FMFD syndrome, type VI
  • Blood coagulation disorder with shortened coagulation time
  • Factor V AND factor VIII deficiency
  • Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
  • East Texas bleeding disorder
  • Abnormal fibrinolysis
  • Familial thrombomodulin anomalies
  • Factor IX AND factor XI deficiency
  • Hereditary factor I deficiency disease
  • Factor V short isoforms related bleeding disorder
  • Blood coagulation disorder with prolonged coagulation time
  • Fibrinolytic bleeding syndrome
  • Drug-induced coagulation inhibitor disorder
  • FMFD syndrome, type II
  • Familial multiple factor deficiency syndrome
  • Acquired anticoagulants
  • FMFD syndrome, type V
  • A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency
  • Factor VIII AND factor IX deficiency
  • A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency (ADAMTS13)
  • Familial multiple factor deficiency syndrome, type I
  • THBD (thrombomodulin) related bleeding disorder
  • Familial multiple factor deficiency syndrome, type II
  • FMFD syndrome, type III
  • COVID-19 associated coagulopathy
  • Factors VII AND VIII deficiency
  • Hypofibrinogenemia
  • Deficiency of naturally occurring coagulation factor inhibitor
  • Blood coagulation disorder with impaired clot retraction time
  • Congenital alpha2-antiplasmin deficiency
  • SARS-CoV-2-Associated Coagulation Disorder
  • Congenital alpha-2-antiplasmin deficiency
  • Familial multiple factor deficiency syndrome, type V
  • P2Y12 defect
  • P2Y12 (purinergic receptor p2y G protein-coupled 12) defect
  • Defect of purinergic receptor p2y G protein-coupled 12
  • Thrombomodulin-related bleeding disorder
  • Hypoplasminogenaemia
  • Familial multiple factor deficiency syndrome, type IV
  • Blood coagulation disorder, categorised by value of screening test
  • Congenital hypofibrinogenemia
  • Pseudoxanthoma elasticum-like syndrome
  • ADP platelet receptor P2Y12 defect
  • Platelet type-von Willebrand disease
  • Congenital hypofibrinogenaemia
  • Hereditary hypoplasminogenemia
  • PT-VWD - platelet type-von Willebrand disease
  • Acquired coagulation factor inhibitor disorder
  • Factor IX inhibitor disorder
  • Blood coagulation disorder with prolonged bleeding time
  • Acquired hypofibrinogenemia
  • Plasminogen deficiency
  • Factor XI inhibitor disorder
  • Body skin hyperlaxity due to vitamin K dependent coagulation factor deficiency
  • FMFD syndrome, type IV
  • COVID-19-Associated Coagulation Disorder
  • Pseudo-von Willebrand disease type 2B
  • FMFD syndrome
  • Acquired fibrinogen abnormality
  • Congenital fibrinogen deficiency
  • Factors VIII, IX AND XI deficiency
  • Congenital fibrinogen abnormality
  • Blood coagulation disorder with shortened bleeding time
  • Acquired coagulation disorder
  • Pseudo von Willebrand disease
  • Antiprothrombin disorder
  • Hereditary hypofibrinogenaemia
  • Afibrinogenaemia
  • Acquired hypoplasminogenaemia
  • Hereditary hypofibrinogenemia
  • Haemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
  • Platelet type pseudo-von Willebrand disease
  • Acquired hypoplasminogenemia
  • PXE (pseudoxanthoma elasticum) like syndrome
  • Hypoplasminogenemia
  • Familial multiple factor deficiency syndrome, type VI
Frequently Asked Questions
What is the ICD-10 code for other specified coagulation defects?

The ICD-10-CM code for other specified coagulation defects is D68.8. The full clinical description is "Other specified coagulation defects". D68.8 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code D68.8 mean?

ICD-10-CM code D68.8 represents “Other specified coagulation defects”. It is classified under Chapter 3: Diseases of the Blood and Blood-Forming Organs and is a billable/specific code that can be used on a claim.

Is D68.8 a billable code?

Yes, D68.8 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is D68.8 in?

D68.8 is in Chapter 3: Diseases of the Blood and Blood-Forming Organs (codes D50-D89).

What codes cannot be used with D68.8?

D68.8 has Excludes1 notes indicating codes that cannot be used together with it, including: abnormal coagulation profile NOS (R79.1); hemorrhagic disease of newborn (P53).

What SNOMED CT codes does D68.8 map to?

D68.8 maps to 51 SNOMED CT concepts: 439725008, 725291001, 30257002, 64509006, 234466008, and 46 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for D68.8?

D68.8 is linked to 2 UMLS Concept Unique Identifiers: C5419174, C0477316. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does D68.8 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like other specified coagulation defects affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of D68.8?

D68.8 maps to the ICD-11 code: 3B4Z (Coagulation defects, unspecified).

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Try FreeView API Docs

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.